Stock UniverseDerived research view · source repositories remain read-only

Emergent BioSolutions Inc. (EBS)

Therapeutics / Biopharma · Healthcare / Drug Manufacturers - Specialty & Generic
Score Band
Speculative
Selection Score
24.21
Global Rank
2896
Market Cap
424.62M
Latest Close
8.07
RS Composite
-21.83% · G#2739

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-11.32%
3M
-2.65%
6M
-30.43%
1Y
27.49%
3Y
-5.39%
5Y
-86.69%
10Y
-81.61%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 700.30K · 30-day average: 787.62K · Max drawdown over stored range: -98.89%

Research Snapshot

Relative Strength vs SPX

RS Composite-21.83%
20D RS-12.25%
60D RS-10.32%
120D RS-38.14%
Global RS Rank2739 · 18.36% percentile
Watch+Speculative RS Rank1676 · 20.08% percentile
Group ScopeWatch+Speculative
Primary RS Rank314 · 31.44% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank355 / 701
Primary Percentile49.50
Score Notesmarket-cap support, industry-tailwind, small-cap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for EBS.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue1577.31773.61117.51049.31043.6742.9
Revenue Growth (YoY)42.613%12.445%-36.993%-6.103%-0.543%-28.814%
Gross Profit863.1793.2290.1254.2311.6421.3
Operating Income499.2386-109.3-168.1-52.2117.1
Free Cash Flow39596.1-149.9-257.935.8156.8
Free Cash Flow Per Share7.3421.776-2.992-5.0370.6752.765
EPS (Diluted) GAAP5.684.06-4.223552-14.853515-3.60.93
EPS Growth446.154%-28.521%8800%8800%8800%
EPS Non-GAAP
Gross Margin54.72%44.723%25.96%24.226%29.858%56.71%
Operating Margin31.649%21.764%-9.781%-16.02%-5.002%15.763%
Profit Margin19.388%12.376%-18.935%-72.477%-18.264%7.08%
Free Cash Flow Margin25.043%5.418%-13.414%-24.578%3.43%21.106%
Shares Outstanding (Diluted)53.854.150.151.25356.7
Shares Change (YoY)2.672%0.558%-7.394%2.196%3.516%6.981%

SEC Quarterly Fundamentals

No processed quarterly rows for EBS.